28 August 2018

Interrad Medical, Inc.

LGB has acted as the European placement agent in the $7.5 million offering of secured convertible notes by Interrad Medical, Inc. (www.securacath.com). 

The company has developed a product platform for the stabilisation of catheters using a sub-cutaneous anchor. In 2H 2017 Interrad received $5.5 million in subscription to its issue of convertible notes. In 1H 2018 the company focussed on business developments, which included being selected for a central procurement contract with NHS England under its Innovation and Technology Payment Programme. More than 250 companies applied with Interrad and only four were successful. As a result of the company's progress, LGB has been able to arrange the issue of the remaining $2 million of notes.

Recent Articles

29 April 2019

AIM for growth businesses looking to scale up is still an option

Ivan Sedgwick, Investments Director at LGB & Co. Limited, wrote an article for Growth Business on why AIM needs to attract institutional interest and improve transparency and governance.


Read more

News & Insights

16 April 2019

Fixed Income Investment for Uncertain Times

Simone Westerhuis, Director of LGB Investments, discusses the fixed income terrain and how different sectors will fare in uncertain economic times.


Read more

News & Insights

29 March 2019

Interrad Makes Progress as it Prepares for Strategic Engagements

Interrad Medical's subcutaneous catheter securement device, SecurAcath, is rapidly becoming the standard of care in hospitals of NHS England and in leading hospitals around the world.


Read more